Before leaving Honolulu, make plans with your colleagues to reconvene for CHEST 2024, October 6-9, in Boston, MA.

Lisa Moores, MD, FCCP, helped guide audience members through a case study of intermediate-risk pulmonary embolism that involved various choices for risk stratification and therapy.

Panelists, including Max Hockstein, MD, MS, provided an overview of the available tools for determining the etiology of shock and their real-world usage.

A Wednesday morning session, chaired by Thomas DeCato, MD, FCCP, will help clinicians navigate the current guidance for pulmonary function tests, address controversial issues, and answer unresolved questions from their daily practice.

A Wednesday morning panel discussion, chaired by Sean Callahan, MD, will help attendees distinguish incidental interstitial lung abnormalities from more consequential findings such as interstitial lung disease.

Listen now for a preview of the day from Chair of the Scientific Program Committee, Aneesa Das, MD, FCCP, and her guest, Chair of CHEST 2024, Gabriel T. Bosslet, MD, FCCP.